AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).

Biotechnology

AltPep

Valerie Daggett

Amy C.

Jeff Posakony, Ph.D.

Jae Hyun Park

Calvin Fries

Nancy Hill

Gil Block

Patrik Edenholm

Charles Horne

Advisory Team

Business Operations Team

Leadership Team

Scientific Research Team

Teams at AltPep

Advisory Team

Business Operations Team

Leadership Team

Scientific Research Team